Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer
Phase 2
Terminated
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2009-12-24
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Optimum Therapeutics, LLC
- Target Recruit Count
- 14
- Registration Number
- NCT01038752
- Locations
- 🇺🇸
John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
🇺🇸Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States